Vibration, Massage, and Myofascial Release in Primary Dysmenorrhea (NCT07731243) | Clinical Trial Compass
RecruitingNot Applicable
Vibration, Massage, and Myofascial Release in Primary Dysmenorrhea
Turkey (Türkiye)96 participantsStarted 2026-07-14
Plain-language summary
This randomized, assessor-blinded, four-arm, parallel-group controlled trial aims to compare the effects of vibration therapy, abdominal massage, and myofascial release with an education-only control intervention in women with primary dysmenorrhea. Seventy-two women aged 18 to 30 years will be randomized in a 1:1:1:1 ratio. All participants will receive standard education about primary dysmenorrhea. The three intervention groups will additionally receive their assigned treatment twice weekly for 12 weeks, covering three menstrual cycles. Menstrual pain, pain characteristics, pressure pain threshold, menstrual symptoms, and symptoms associated with central sensitization will be evaluated at baseline and after the intervention by a blinded assessor.
Who can participate
Age range
18 Years – 30 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
* Inclusion Criteria:
* Female participants aged 18 to 30 years.
* Having regular menstrual cycles during the previous 6 months.
* Having a diagnosis consistent with primary dysmenorrhea following evaluation by an obstetrician and gynecologist.
* Experiencing menstrual pain in at least 2 of the previous 3 menstrual cycles.
* Having menstrual pain intensity of 4 or higher on a 0-10 Visual Analog Scale.
* Voluntarily agreeing to participate in the study and providing written informed consent.
Exclusion Criteria:
* Secondary dysmenorrhea.
* Diagnosis of endometriosis, uterine fibroids, ovarian cysts, or pelvic inflammatory disease.
* History of gynecological surgery.
* Pregnancy or suspected pregnancy.
* Having given birth within the previous 6 months.
* Recent initiation of hormonal treatment.
* Chronic pelvic pain or a neurological, rheumatological, or systemic inflammatory disease.
* Having received manual therapy or physiotherapy targeting the abdominal or lumbopelvic region within the previous 3 months.
* Skin lesions, infection, open wounds, or other dermatological conditions in the treatment regions.
* Any clinical condition considered a contraindication to vibration therapy.
* Inability to comply with the study protocol -
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Short-Form McGill Pain Questionnaire (SF-MPQ) Total Score
Timeframe: Baseline and post-intervention at Week 12